Patient characteristics
| Characteristic | Oral steroids | IV steroids | Analysis type | p Value |
| Patients (n=73) | 30 | 43 | ||
| Unilateral eye involvement (n=56) (77%) | 24 | 32 | ||
| Bilateral (n=17) (23%) | 6 | 11 | χ2 | 0.53 |
| Right eye (n=37) (51%) | 17 | 20 | χ2 | 0.05 |
| Mean age (SD 7) | 73 | 76 | t test | <0.001 |
| Female (n=49) (67%) | 18 | 31 | χ2 | 0.04 |
| Treatment dose (median) (mg/day) | 75 | 1000 | ||
| Treatment within 48 hours of symptoms | 30 | 43 | ||
| VA on presentation | ||||
| 6/12 or better (0.3) | 13 | 8 | χ2 | 0.35 |
| 6/18 to 6/36 (0.5–0.8) | 5 | 4 | χ2 | 0.64 |
| 6/60 or worse | 12 | 31 | χ2 | 0.04 |